These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 24152416)

  • 1. Evidence for continuous glucose monitoring: sufficient for reimbursement?
    Heinemann L; DeVries JH
    Diabet Med; 2014 Feb; 31(2):122-5. PubMed ID: 24152416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reimbursement for Continuous Glucose Monitoring.
    Heinemann L; DeVries JH
    Diabetes Technol Ther; 2016 Feb; 18 Suppl 2(Suppl 2):S248-52. PubMed ID: 26784130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of reimbursement in the adoption of continuous glucose monitors.
    Bartelme A; Bridger P
    J Diabetes Sci Technol; 2009 Jul; 3(4):992-5. PubMed ID: 20144351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Future of diabetes-technology: certificate of competency for insulin pumps and continuous glucose monitors.
    Heinemann L; Faber-Heinemann G; Roberts R; Walsh J
    J Diabetes Sci Technol; 2012 Jul; 6(4):725-7. PubMed ID: 22920796
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical review: Realistic expectations and practical use of continuous glucose monitoring for the endocrinologist.
    Hirsch IB
    J Clin Endocrinol Metab; 2009 Jul; 94(7):2232-8. PubMed ID: 19383778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variations in access to and reimbursement for continuous glucose monitoring systems for people living with Type 1 diabetes across England.
    Perera R; Oliver N; Wilmot E; Marriott C
    Diabet Med; 2018 Nov; 35(11):1617-1618. PubMed ID: 29931731
    [No Abstract]   [Full Text] [Related]  

  • 8. Reimbursement for continuous glucose monitoring: a European view.
    Heinemann L; Franc S; Phillip M; Battelino T; Ampudia-Blasco FJ; Bolinder J; Diem P; Pickup J; Hans Devries J
    J Diabetes Sci Technol; 2012 Nov; 6(6):1498-502. PubMed ID: 23294797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic education and continuous glucose monitoring in insulin-treated diabetic patients].
    Thielen V; Radermecker RP; Renard E; Bringer J; Scheen AJ
    Rev Med Suisse; 2010 Sep; 6(260):1596-600. PubMed ID: 20853714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of devices in diabetes management.
    Penfornis A; Personeni E; Borot S
    Diabetes Technol Ther; 2011 Jun; 13 Suppl 1():S93-102. PubMed ID: 21668342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of clinical trial design on cost-effectiveness analyses: illustration from a published study of the one-touch ultrasmart blood glucose meter for insulin-using diabetes patients.
    Tunis SL; Minshall ME
    Diabetes Technol Ther; 2008 Jun; 10(3):227-31. PubMed ID: 18473698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obtaining reimbursement in France and Italy for new diabetes products.
    Schaefer E; Schnell G; Sonsalla J
    J Diabetes Sci Technol; 2015 Jan; 9(1):156-61. PubMed ID: 25550411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reimbursement and coverage implications for CGM.
    Aubry W
    Diabetes Technol Ther; 2005 Oct; 7(5):797-800. PubMed ID: 16241886
    [No Abstract]   [Full Text] [Related]  

  • 14. [Usefulness of continuous glucose monitoring system (CGMS) in monitoring glycaemic profile in small children with diabetes type 1].
    Głowińska-Olszewska B; Urban M; Peczyńska J; Florys B; Kowalewski M
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(4):237-43. PubMed ID: 16232362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calculation of the best basal-bolus combination for postprandial glucose control in insulin pump therapy.
    Revert A; Calm R; Vehi J; Bondia J
    IEEE Trans Biomed Eng; 2011 Feb; 58(2):274-81. PubMed ID: 20639170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized pilot study in Type 1 diabetes complicated by severe hypoglycaemia, comparing rigorous hypoglycaemia avoidance with insulin analogue therapy, CSII or education alone.
    Thomas RM; Aldibbiat A; Griffin W; Cox MA; Leech NJ; Shaw JA
    Diabet Med; 2007 Jul; 24(7):778-83. PubMed ID: 17535290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous glucose monitoring and diabetes health outcomes: a critical appraisal.
    Reach G
    Diabetes Technol Ther; 2008 Apr; 10(2):69-80. PubMed ID: 18260770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Costs of the treatment of hyperglycemia in patients with diabetes mellitus. The impact of age, type of therapy and complications: results of the German CoDiM study].
    von Ferber L; Köster I; Hauner H
    Med Klin (Munich); 2006 May; 101(5):384-93. PubMed ID: 16685485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simulation based cost-benefit analysis of a telemedical system for closed-loop insulin pump therapy of diabetes.
    Bott OJ; Hoffmann I; Bergmann J; Kosche P; von Ahn C; Mattfeld DC; Schnell O; Pretschner DP
    Stud Health Technol Inform; 2006; 124():435-40. PubMed ID: 17108558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose monitoring and pump data management software operated on a personal digital assistant can contribute to improve diabetes control in CSII-treated patients.
    Boizel R; Benhamou PY; Renard E;
    Diabetes Metab; 2007 Sep; 33(4):314-5. PubMed ID: 17475533
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.